Page last updated: 2024-08-21

pyrazines and Ecchymosis

pyrazines has been researched along with Ecchymosis in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's2 (100.00)2.80

Authors

AuthorsStudies
Bossory Goike, L; Dean, S1
Beylot-Barry, M; Protin, C; Recher, C; Sibaud, V; Vigarios, E; Ysebaert, L1

Reviews

1 review(s) available for pyrazines and Ecchymosis

ArticleYear
Dermatological Toxicities of Bruton's Tyrosine Kinase Inhibitors.
    American journal of clinical dermatology, 2020, Volume: 21, Issue:6

    Topics: Adenine; Administration, Cutaneous; Agammaglobulinaemia Tyrosine Kinase; Benzamides; Biopsy; Drug Eruptions; Ecchymosis; Emollients; Humans; Incidence; Leukemia, Lymphocytic, Chronic, B-Cell; Necrosis; Patient Education as Topic; Piperidines; Protein Kinase Inhibitors; Pyrazines; Pyrazoles; Pyrimidines; Receptors, Antigen, B-Cell; Severity of Illness Index; Signal Transduction; Skin; Skin Care

2020

Other Studies

1 other study(ies) available for pyrazines and Ecchymosis

ArticleYear
Images in Vascular Medicine. Rumpel-Leede phenomenon in a patient with chronic lymphocytic leukemia treated with acalabrutinib.
    Vascular medicine (London, England), 2020, Volume: 25, Issue:3

    Topics: Agammaglobulinaemia Tyrosine Kinase; Aged, 80 and over; Antineoplastic Agents; Benzamides; Capillary Fragility; Chronic Disease; Ecchymosis; Female; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Molecular Targeted Therapy; Protein Kinase Inhibitors; Pyrazines; Risk Factors; Stockings, Compression; Treatment Outcome; Venous Insufficiency

2020